Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate

Seizure

Volumn 8, Issue 4, 1999, Pages 253-254

  Craig, John ^a   Morrison, Patrick ^b   Morrow, Jim ^a   Patterson, Victor ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Folic acid; Neural tube defect; Sodium valproate

Indexed keywords

FOLIC ACID; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MALE; NEURAL TUBE DEFECT; NEWBORN; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0033150223     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.1999.0283     Document Type: Article

References (14)

1. Lindhout, D. and Meinardi, H. Spina bifida and in utero exposure to valproate. Lancet 1994; 343: 396.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
3. Clayton-Smith, J. and Donnai, D. Fetal valproate syndrome. Journal of Medical Genetics 1995; 32: 724-727.
4. Van Allen, M. I., Kalousek, D. K., Chernoff, G. F., et al. Evidence for multi-site closure of the neural tube in humans. American Journal of Medical Genetics 1993; 47: 723-743.
5. Trotz, M., Wegner, S. and Nau, H. Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse. Life Sciences 1987; 41: 103-110.
6. Elmazar, M. M. A., Thiel, T. and Nau, H. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice. Fundamental Applied Toxicology 1992; 18: 389-394.
7. Essien, F. B. and Wannberg, S. L. Methionine but not folinic acid or vitamin B12 alters the frequency of neural tube defects in Axd mutant mice. Journal of Nutrition 1993; 123: 27-34.
8. Hansen, D. K., Grafton, T. F., Dial, S. L., Gehring, T. A. and Sitonen, P. H. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo. Teratology 1995; 52: 277-285.
9. Dansky, L. V., Rosenblatt, D. A. and Andermann, E. Mechanisms of teratogenesis: Folic acid and antiepileptic therapy. Neurology 1992; 42 (Suppl. 5): 32-42.
10. Kishi, T., Fujita, N., Eguchi, T. and Ueda, K. Mechanism for the reduction of serum folate by antiepileptic drugs during prolonged therapy. Journal of Neurological Science 1997; 145: 109-112.
11. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity Mortality Weekly Report 1992; 41: 1-7.
12. Werler, M. W., Schapiro, S. and Mitchell, A. A. Periconceptual folic acid exposure and risk of occurrent neural-tube defects. Journal of the American Medical Association. 1993; 269: 1257-1261.
13. Daly, S., Mills, J. L., Molloy, A. M., et al. Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet 1997; 350: 1666-1669.
14. Czeizel, A. E. and Dudas, I. Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. New England Journal of Medicine 1992; 327: 1832-1835.